Narcolepsy: a review

References

• DanielsLENarcolepsyMedicine1934131122
   Google Scholar
• ZorickFJSalisPJRothTKramerMNarcolepsy and automatic behavior: A case reportJ Clin Psychiatry1979404194197422531
   PubMed Web of Science ®Google Scholar
• ParkesJDBaraitserMMarsdenCDAsselmanPNatural history, symptoms and treatment of the narcoleptic syndromeActa Neurol Scand197552533735319899267
   PubMed Web of Science ®Google Scholar
• BroughtonRGhanemQHishikawaYSugitaYNevsimalovaSRothBLife effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controlsCan J Neurol Sci1981842993047326610
   PubMed Web of Science ®Google Scholar
• ParkesJDFentonGStruthersGNarcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findingsQ J Med1974431725255364533510
   PubMedGoogle Scholar
• MorrishEKingMASmithIEShneersonJMFactors associated with a delay in the diagnosis of narcolepsySleep Med200451374114725825
   PubMed Web of Science ®Google Scholar
• SansaGIranzoASantamariaJObstructive sleep apnea in narcolepsySleep Med2010111939519699146
   PubMed Web of Science ®Google Scholar
• FerriRFranceschiniCZucconiMSleep polygraphic study of children and adolescents with narcolepsy/cataplexyDev Neuropsychol200934552353820183716
   PubMed Web of Science ®Google Scholar
• KnudsenSGammeltoftSJennumPJRapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiencyBrain2010133Pt 256857920129934
   PubMed Web of Science ®Google Scholar
• SchenckCHMahowaldMWMotor dyscontrol in narcolepsy: Rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorderAnn Neurol19923213101642469
   PubMed Web of Science ®Google Scholar
• SchenckCHHurwitzTDBundlieSRMahowaldMWSleep-related eating disorders: Polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disordersSleep19911454194311759095
   PubMed Web of Science ®Google Scholar
• SpaggiariMCGranellaFParrinoLMarchesiCMelliITerzanoMGNocturnal eating syndrome in adultsSleep19941743393447973318
   PubMed Web of Science ®Google Scholar
• OhayonMMPriestRGZulleyJSmirneSPaivaTPrevalence of narcolepsy symptomatology and diagnosis in the European general populationNeurology200258121826183312084885
   PubMed Web of Science ®Google Scholar
• HeierMSEvsiukovaTWilsonJAbdelnoorMHublinCErvikSPrevalence of narcolepsy with cataplexy in NorwayActa Neurol Scand2009120427628019456307
   PubMed Web of Science ®Google Scholar
• DohertyLCroweCSweeneyBNational narcolepsy surveyIr Med J20101034112113
   Google Scholar
• WilnerASteinmanLLaviePPeledRFriedmannABrautbarCNarcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic levelHum Immunol198821115222896649
   PubMed Web of Science ®Google Scholar
• TashiroTKanbayashiTIijimaSHishikawaYAn epidemiological study of narcolepsy in JapaneseJ Sleep Res19921228
   Google Scholar
• PeacockJBencaRMNarcolepsy: Clinical features, co-morbidities and treatmentIndian J Med Res201013133834920308759
   PubMed Web of Science ®Google Scholar
• PetersonPCHusainAMPediatric narcolepsyBrain Dev2008301060962318375081
   PubMed Web of Science ®Google Scholar
• MignotEHaydukRBlackJGrumetFCGuilleminaultCHLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patientsSleep19972011101210209456467
   PubMed Web of Science ®Google Scholar
• SilberMHKrahnLEOlsonEJPankratzVSThe epidemiology of narcolepsy in Olmsted County, Minnesota: A population-based studySleep200225219720211902429
   PubMed Web of Science ®Google Scholar
• NishinoSOkuraMMignotENarcolepsy: Genetic predisposition and neuropharmacological mechanismsSleep Med Rev200041579912531161
   PubMed Web of Science ®Google Scholar
• MignotEGenetic and familial aspects of narcolepsyNeurology1998502 Suppl 1S16229484418
   PubMed Web of Science ®Google Scholar
• AranALinLNevsimalovaSElevated anti-streptococcal antibodies in patients with recent narcolepsy onsetSleep200932897998319725248
   PubMed Web of Science ®Google Scholar
• LongstrethWTJrTonTGKoepsellTDNarcolepsy and streptococcal infectionsSleep20093212154820041589
   PubMed Web of Science ®Google Scholar
• DauvilliersYMontplaisirJCochenVPost-H1N1 narcolepsy-cataplexySleep201033111428143021102981
   PubMed Web of Science ®Google Scholar
• TonTGLongstrethWTJrKoepsellTDEnvironmental toxins and risk of narcolepsy among people with HLA DQB1*0602Environ Res2010110656557020519130
   PubMed Web of Science ®Google Scholar
• TaftiMGenetic aspects of normal and disturbed sleepSleep Med200910Suppl 1S172119660984
   PubMed Web of Science ®Google Scholar
• MignotELinLRogersWComplex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groupsAm J Hum Genet200168368669911179016
   PubMed Web of Science ®Google Scholar
• HorHKutalikZDauvilliersYGenome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsyNat Genet201042978678920711174
   PubMed Web of Science ®Google Scholar
• HongSCLinLJeongJHA study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepinessSleep200629111429143817162989
   PubMed Web of Science ®Google Scholar
• SutcliffeJGde LeceaLThe hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feedingJ Neurosci Res200062216116811020209
   PubMed Web of Science ®Google Scholar
• ThorpyMTherapeutic advances in narcolepsySleep Med20078442744017475553
   PubMed Web of Science ®Google Scholar
• ShibataMMondalMSDateYNakazatoMSuzukiHUetaYDistribution of orexins-containing fibers and contents of orexins in the rat olfactory bulbNeurosci Res20086119910518355936
   PubMed Web of Science ®Google Scholar
• JonesBEModulation of cortical activation and behavioral arousal by cholinergic and orexinergic systemsAnn N Y Acad Sci20081129263418591466
   PubMed Web of Science ®Google Scholar
• FoutzASMitlerMMCavalli-SforzaLLDementWCGenetic factors in canine narcolepsySleep197914413421574310
   PubMed Web of Science ®Google Scholar
• LinLFaracoJLiRThe sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 geneCell199998336537610458611
   PubMed Web of Science ®Google Scholar
• NishinoSRipleyBOvereemSLammersGJMignotEHypocretin (orexin) deficiency in human narcolepsyLancet20003559197394010615891
   PubMed Web of Science ®Google Scholar
• ThannickalTCMooreRYNienhuisRReduced number of hypocretin neurons in human narcolepsyNeuron200027346947411055430
   PubMed Web of Science ®Google Scholar
• PeyronCFaracoJRogersWA mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsNat Med20006999199710973318
   PubMed Web of Science ®Google Scholar
• BlackJL3rdSilberMHKrahnLEStudies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602- positive narcoleptic subjects with cataplexyBiol Psychiatry200558650450916043129
   PubMed Web of Science ®Google Scholar
• BlackJL3rdSilberMHKrahnLEAnalysis of hypocretin (orexin) antibodies in patients with narcolepsySleep200528442743116171287
   PubMed Web of Science ®Google Scholar
• GledhillRFBartelPRYoshidaYNishinoSScammellTENarcolepsy caused by acute disseminated encephalomyelitisArch Neurol200461575876015148155
   PubMedGoogle Scholar
• JacksonMWReedJHSmithAJGordonTPAn autoantibody in narcolepsy disrupts colonic migrating motor complexesJ Neurosci20082849133031330919052222
   PubMed Web of Science ®Google Scholar
• ZhangYDavisJLLiWIdentification of Tribbles homolog 2 as an autoantigen in autoimmune uveitis by phage displayMol Immunol200542111275128115950723
   PubMed Web of Science ®Google Scholar
• Cvetkovic-LopesVBayerLDorsazSElevated Tribbles homolog 2-specific antibody levels in narcolepsy patientsJ Clin Invest2010120371371920160349
   PubMed Web of Science ®Google Scholar
• ToyodaHTanakaSMiyagawaTHondaYTokunagaKHondaMAnti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsySleep201033787587820614847
   PubMed Web of Science ®Google Scholar
• HallmayerJFaracoJLinLNarcolepsy is strongly associated with the T-cell receptor alpha locusNat Genet200941670871119412176
   PubMed Web of Science ®Google Scholar
• Hinze-SelchDWetterTCZhangYIn vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controlsNeurology1998504114911529566413
   PubMed Web of Science ®Google Scholar
• OkunMLGieseSLinLEinenMMignotECoussons-ReadMEExploring the cytokine and endocrine involvement in narcolepsyBrain Behav Immun200418432633215157949
   PubMed Web of Science ®Google Scholar
• HimmerichHBeitingerPAFuldaSPlasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsyArch Intern Med2006166161739174316983052
   PubMedGoogle Scholar
• FontanaAGastHReithWRecherMBirchlerTBassettiCLNarcolepsy: Autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?Brain2010133Pt 51300131120403960
   PubMed Web of Science ®Google Scholar
• KanbayashiTIshiguroHAizawaRHypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain- Barre syndromePsychiatry Clin Neurosci200256327327412047592
   PubMed Web of Science ®Google Scholar
• NishinoSKanbayashiTFujikiNCSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathiesNeurology200361682382514504329
   PubMed Web of Science ®Google Scholar
• BourginPZeitzerJMMignotECSF hypocretin-1 assessment in sleep and neurological disordersLancet Neurol20087764966218565458
   PubMed Web of Science ®Google Scholar
• Von EconomoCEncephalitis lethargicaWeiner Medizinische Wochenschrift192373777782
   Google Scholar
• AldrichMSNaylorMWNarcolepsy associated with lesions of the diencephalonNeurology19893911150515082812331
   PubMed Web of Science ®Google Scholar
• NishinoSKanbayashiTSymptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin systemSleep Med Rev20059426931016006155
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep MedicineThe International Classification of Sleep Disorders, Diagnostic and Coding Manual2nd edWestchester, ILAmerican Academy of Sleep Medicine2005
   Google Scholar
• JohnsMWA new method for measuring daytime sleepiness: The Epworth sleepiness scaleSleep19911465405451798888
   PubMed Web of Science ®Google Scholar
• SullivanSSKushidaCAMultiple sleep latency test and maintenance of wakefulness testChest2008134485486118842919
   PubMed Web of Science ®Google Scholar
• NguyenATBaltzanMASmallDWolkoveNGuillonSPalayewMClinical reproducibility of the Epworth Sleepiness ScaleJ Clin Sleep Med20062217017417557491
   PubMed Web of Science ®Google Scholar
• DeZeeKJJacksonJLHatzigeorgiouCKristoDThe Epworth sleepiness scale: Relationship to sleep and mental disorders in a sleep clinicSleep Med20067432733216564218
   PubMed Web of Science ®Google Scholar
• IzciBArdicSFiratHSahinAAltinorsMKaracanIReliability and validity studies of the Turkish version of the Epworth Sleepiness ScaleSleep Breath200812216116817922157
   PubMed Web of Science ®Google Scholar
• ChenNHJohnsMWLiHYValidation of a Chinese version of the Epworth sleepiness scaleQual Life Res200211881782112482165
   PubMed Web of Science ®Google Scholar
• KokSWMeindersAEOvereemSReduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humansJ Clin Endocrinol Metab200287280580911836325
   PubMed Web of Science ®Google Scholar
• LittnerMRKushidaCWiseMPractice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness testSleep200528111312115700727
   PubMed Web of Science ®Google Scholar
• CarskadonMADementWCMitlerMMRothTWestbrookPRKeenanSGuidelines for the multiple sleep latency test (MSLT): A standard measure of sleepinessSleep1986945195243809866
   PubMed Web of Science ®Google Scholar
• RackMDavisJRoffwargHPRichertABaranASThe Multiple Sleep Latency Test in the diagnosis of narcolepsyAm J Psychiatry2005162112198219916263876
   PubMed Web of Science ®Google Scholar
• AllenRPWhen, if ever, can we use REM-onset naps on the MSLT for the diagnosis of narcolepsy?Sleep Med20067865765917098471
   PubMed Web of Science ®Google Scholar
• MorrisonIBuskovaJNevsimalovaSDouglasNJRihaRLDiagnosing narcolepsy with cataplexy on history alone: Challenging the International Classification of Sleep Disorders (ICSD-2) criteriaEur J Neurol20111871017102021658163
   PubMed Web of Science ®Google Scholar
• SangalRBThomasLMitlerMMMaintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disordersChest199210148989021555459
   PubMed Web of Science ®Google Scholar
• BenbadisSRMaschaEPerryMCWolgamuthBRSmolleyLADinnerDSAssociation between the Epworth sleepiness scale and the multiple sleep latency test in a clinical populationAnn Intern Med19991304 Pt 128929210068387
   PubMed Web of Science ®Google Scholar
• PlazziGMontagnaPProviniFBizziACohenMLugaresiEPontine lesions in idiopathic narcolepsyNeurology1996465125012548628461
   PubMed Web of Science ®Google Scholar
• BassettiCAldrichMSQuintDJMRI findings in narcolepsySleep19972086306319351130
   PubMed Web of Science ®Google Scholar
• FreyJLHeisermanJEAbsence of pontine lesions in narcolepsyNeurology1997484109710999109908
   PubMed Web of Science ®Google Scholar
• StepienAStaszewskiJDomzalTMTomczykiewiczKSkrobowskaEDurka-KesyMDegenerative pontine lesions in patients with familial narcolepsyNeurol Neurochir Pol20104412127 Polish20358482
   PubMed Web of Science ®Google Scholar
• EllisCMSimmonsALemmensGWilliamsSCParkesJDProton spectroscopy in the narcoleptic syndrome. Is there evidence of a brainstem lesion?Neurology1998502 Suppl 1S23269484419
   PubMed Web of Science ®Google Scholar
• LodiRTononCVignatelliLIn vivo evidence of neuronal loss in the hypothalamus of narcoleptic patientsNeurology20046381513151515505179
   PubMed Web of Science ®Google Scholar
• JooEYHongSBTaeWSCerebral perfusion abnormality in narcolepsy with cataplexyNeuroImage200528241041616098766
   PubMed Web of Science ®Google Scholar
• HongSBTaeWSJooEYCerebral perfusion changes during cataplexy in narcolepsy patientsNeurology200666111747174916769955
   PubMed Web of Science ®Google Scholar
• BoulosMIMurrayBJCurrent evaluation and management of excessive daytime sleepinessCan J Neurol Sci201037216717620437926
   PubMed Web of Science ®Google Scholar
• ArnulfIExcessive daytime sleepiness in parkinsonismSleep Med Rev20059318520015893249
   PubMed Web of Science ®Google Scholar
• LeeJHBliwiseDLAnsariFPDaytime sleepiness and functional impairment in Alzheimer diseaseAm J Geriatr Psychiatry200715762062617586786
   PubMed Web of Science ®Google Scholar
• ErvikSAbdelnoorMHeierMSRambergMStrandGHealthrelated quality of life in narcolepsyActa Neurol Scand2006114319820416911349
   PubMed Web of Science ®Google Scholar
• RiemannDInsomnia and comorbid psychiatric disordersSleep Med20078Suppl 4S152018346672
   PubMed Web of Science ®Google Scholar
• NaumannABellebaumCDaumICognitive deficits in narcolepsyJ Sleep Res200615332933816911036
   PubMed Web of Science ®Google Scholar
• BhatSKGalangRNarcolepsy presenting as schizophreniaAm J Psychiatry20021597124512091214
   PubMed Web of Science ®Google Scholar
• KondziellaDArlien-SoborgPDiagnostic and therapeutic challenges in narcolepsy-related psychosisJ Clin Psychiatry200667111817181917196065
   PubMed Web of Science ®Google Scholar
• KishiYKonishiSKoizumiSKudoYKurosawaHKatholRGSchizophrenia and narcolepsy: A review with a case reportPsychiatry Clin Neurosci200458211712415009814
   PubMed Web of Science ®Google Scholar
• MoturiSIvanenkoAComplex diagnostic and treatment issues in psychotic symptoms associated with narcolepsyPsychiatry (Edgmont)200966384419724760
   PubMedGoogle Scholar
• Yasui-FurukoriNKusunokiMKanekoSHallucinations associated with modafinil treatment for narcolepsyJ Clin Psychopharmacol200929440819593192
   PubMed Web of Science ®Google Scholar
• DahmenNKastenMMittagKMullerMJNarcoleptic and schizophrenic hallucinations. Implications for differential diagnosis and pathophysiologyEur J Health Econ20023Suppl 2S949815609161
   PubMedGoogle Scholar
• NevsimalovaSNarcolepsy in childhoodSleep Med Rev200913216918019153053
   PubMed Web of Science ®Google Scholar
• FejermanNNonepileptic disorders imitating generalized idiopathic epilepsiesEpilepsia200546Suppl 9808316302879
   PubMed Web of Science ®Google Scholar
• CalabroRSSavicaRLaganaAStatus cataplecticus misdiagnosed as recurrent syncopeNeurol Sci200728633633818175082
   PubMed Web of Science ®Google Scholar
• MacleodSFerrieCZuberiSMSymptoms of narcolepsy in children misinterpreted as epilepsyEpileptic Disord200571131715741135
   PubMed Web of Science ®Google Scholar
• Centre for Evidence-based MedicineLevels of evidence 2009 [web page on the Internet]OxfordCentre for Evidence-based Medicine2009 [updated April 15, 2011]. Available from: http://www.cebm.net/index.aspx?o=1025Accessed April 20, 2011
   Google Scholar
• LittnerMJohnsonSFMcCallWVPractice parameters for the treatment of narcolepsy: An update for 2000Sleep200124445146611403530
   PubMed Web of Science ®Google Scholar
• WangWWangFZhaoYLvMLvXTwo patients with narcolepsy treated by hypnotic psychotherapySleep Med20091010116719766057
   PubMed Web of Science ®Google Scholar
• HusainAMYancyWSJrCarwileSTMillerPPWestmanECDiet therapy for narcolepsyNeurology200462122300230215210901
   PubMed Web of Science ®Google Scholar
• MorgenthalerTIKapurVKBrownTPractice parameters for the treatment of narcolepsy and other hypersomnias of central originSleep200730121705171118246980
   PubMed Web of Science ®Google Scholar
• MurrayTJFoleyANarcolepsyCan Med Assoc J1974110163664809449
   PubMed Web of Science ®Google Scholar
• WeitznerHAInsulin hypoglycemia in treatment of narcolepsy with temporary improvementPerm Found Med Bull1952101–415315614948373
   PubMedGoogle Scholar
• SandykREfficacy of trazodone in narcolepsyEur Neurol19852453353374054183
   PubMed Web of Science ®Google Scholar
• IijimaSSugitaYTeshimaYHishikawaYTherapeutic effects of mazindol on narcolepsySleep198691 Pt 22652683704452
   PubMed Web of Science ®Google Scholar
• KalesACadieuxRSoldatosCRTanTLSuccessful treatment of narcolepsy with propranolol: A case reportArch Neurol19793610650651485897
   PubMedGoogle Scholar
• Meier-EwertKMatsubayashiKBenterLPropranolol: Long-term treatment in narcolepsy-cataplexySleep198582951043925525
   PubMed Web of Science ®Google Scholar
• LammersGJArendsJDeclerckACKamphuisenHASchouwinkGTroostJRitanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsySleep19911421301321678203
   PubMed Web of Science ®Google Scholar
• MayerGRitanserin improves sleep quality in narcolepsyPharmacopsychiatry200336415015512905101
   PubMed Web of Science ®Google Scholar
• MayerGEwert MeierKHephataKSelegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled studyClin Neuropharmacol19951843063198665543
   PubMed Web of Science ®Google Scholar
• PrinzmetalMBloombergWThe use of benzedrine for the treatment of narcolepsyJAMA19351052520512054
   Google Scholar
• BilliardMNarcolepsy: Current treatment options and future approachesNeuropsychiatr Dis Treat20084355756618830438
   PubMedGoogle Scholar
• BermanSMKuczenskiRMcCrackenJTLondonEDPotential adverse effects of amphetamine treatment on brain and behavior: A reviewMol Psychiatry200914212314218698321
   PubMed Web of Science ®Google Scholar
• JiaoXVelezSRingstadJEymaVMillerDBleibergMMyocardial infarction associated with adderall XR and alcohol use in a young manJ Am Board Fam Med200922219720119264944
   PubMed Web of Science ®Google Scholar
• MitlerMMHajdukovicRErmanMKTreatment of narcolepsy with methamphetamineSleep19931643063178341891
   PubMed Web of Science ®Google Scholar
• MitlerMMHajdukovicRErmanMKoziolJANarcolepsyJ Clin Neurophysiol199071931181968069
   PubMed Web of Science ®Google Scholar
• HondaYHishikawaYTakahashiYLong-term treatment of narcolepsy with methylphenidate (Ritalin)Curr Ther Res197925288298
   Web of Science ®Google Scholar
• VolkowNDFowlerJSLoganJEffects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implicationsJAMA2009301111148115419293415
   PubMed Web of Science ®Google Scholar
• HuangQZhangLTangHWangLWangYModafinil modulates GABA-activated currents in rat hippocampal pyramidal neuronsBrain Res20081208747818395702
   PubMed Web of Science ®Google Scholar
• [No authors listed]Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study GroupAnn Neurol199843188979450772
   PubMed Web of Science ®Google Scholar
• [No authors listed]Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study GroupNeurology20005451166117510720292
   PubMed Web of Science ®Google Scholar
• BroughtonRJFlemingJAGeorgeCFRandomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsyNeurology19974924444519270575
   PubMed Web of Science ®Google Scholar
• SchwartzJRFeldmanNTBoganRKNelsonMTHughesRJDosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsyClin Neuropharmacol200326525225714520165
   PubMed Web of Science ®Google Scholar
• SchwartzJRFeldmanNTBoganRKDose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepinessJ Neuropsychiatry Clin Neurosci200517340541216179665
   PubMed Web of Science ®Google Scholar
• SaletuBFreyRKrupkaMAndererPGrunbergerJBarbanojMJDifferential effects of a new central adrenergic agonist – modafinil – and D-amphetamine on sleep and early morning behaviour in young healthy volunteersInt J Clin Pharmacol Res1989931831952568348
   PubMedGoogle Scholar
• MitlerMMHarshJHirshkowitzMGuilleminaultCLong-term efficacy and safety of modafinil (PROVIGIL R) for the treatment of excessive daytime sleepiness associated with narcolepsySleep Med20001323124310828434
   PubMed Web of Science ®Google Scholar
• HarshJRHaydukRRosenbergRThe efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsyCurr Med Res Opin200622476177416684437
   PubMed Web of Science ®Google Scholar
• GolickiDBalaMMNiewadaMWierzbickaAModafinil for narcolepsy: Systematic review and meta-analysisMed Sci Monit2010168RA17718620671626
   PubMed Web of Science ®Google Scholar
• AkimotoHHondaYTakahashiYPharmacotherapy in narcolepsyDis Nerv Syst19602170470613681922
   PubMedGoogle Scholar
• GuilleminaultCRaynalDTakahashiSCarskadonMDementWEvaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochlorideActa Neurol Scand19765417187936975
   PubMed Web of Science ®Google Scholar
• HishikawaYIdaHNakaiKKanekoZTreatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (Pertofran)J Neurol Sci1966354534614380880
   PubMed Web of Science ®Google Scholar
• GuilleminaultCWilsonRADementWCA study on cataplexyArch Neurol19743142552614369737
   PubMedGoogle Scholar
• HoughtonWCScammellTEThorpyMPharmacotherapy for cataplexySleep Med Rev20048535536615336236
   PubMed Web of Science ®Google Scholar
• FreyJDarbonneCFluoxetine suppresses human cataplexy: A pilot studyNeurology19944447077098164831
   PubMed Web of Science ®Google Scholar
• LangdonNShindlerJParkesJDBandakSFluoxetine in the treatment of cataplexySleep1986923713733509809
   PubMed Web of Science ®Google Scholar
• IzziFPlacidiFMarcianiMGEffective treatment of narcolepsy-cataplexy with duloxetine: A report of three casesSleep Med200910115315418226953
   PubMed Web of Science ®Google Scholar
• MollerLROstergaardJRTreatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinationsJ Child Adolesc Psychopharmacol200919219720119364297
   PubMed Web of Science ®Google Scholar
• GuilleminaultCMancusoJSalvaMAViloxazine hydrochloride in narcolepsy: A preliminary reportSleep198691 Pt 22752793704453
   PubMed Web of Science ®Google Scholar
• SchraderHKayedKBendixen MarksetACTreideneHEThe treatment of accessory symptoms in narcolepsy: A double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placeboActa Neurol Scand19867442973033544654
   PubMed Web of Science ®Google Scholar
• LapierreOMontplaisirJLamarreMBedardMAThe effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: Further considerations on REM sleep-triggering mechanismsSleep199013124302406848
   PubMed Web of Science ®Google Scholar
• MamelakMBlackJMontplaisirJRistanovicRA pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsySleep20042771327133415586785
   PubMed Web of Science ®Google Scholar
• [No authors listed]A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsySleep2002251424911833860
   PubMed Web of Science ®Google Scholar
• [No authors listed]Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsySleep Med20045211912315033130
   PubMed Web of Science ®Google Scholar
• BlackJPardiDHornfeldtCSInhaberNThe nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: A double-blind, placebo-controlled study in patients with narcolepsyJ Clin Sleep Med20106659660221206549
   PubMed Web of Science ®Google Scholar
• [No authors listed]A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsySleep2003261313512627729
   PubMed Web of Science ®Google Scholar
• PoryazovaRTartarottiSKhatamiRSodium oxybate in narcolepsy with cataplexy: Zurich sleep center experienceEur Neurol201165317518221389728
   PubMed Web of Science ®Google Scholar
• ZvosecDLSmithSWHallBJThree deaths associated with use of XyremSleep Med200910449049319269893
   PubMed Web of Science ®Google Scholar
• HansonLRMartinezPTaheriSKamshehLMignotEFreyWIIIntranasal administration of hypocretin 1 (orexin A) bypasses the blood-brain barrier and targets the brain: A new strategy for the treatment of narcolepsyDrug Delivery Technol200446571
   Google Scholar
• MiedaMWillieJTHaraJSintonCMSakuraiTYanagisawaMOrexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in miceProc Natl Acad Sci U S A2004101134649465415070772
   PubMed Web of Science ®Google Scholar
• PlazziGPoliFFranceschiniCIntravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexyJ Neurol2008255101549155418769859
   PubMed Web of Science ®Google Scholar
• ValkoPOKhatamiRBaumannCRBassettiCLNo persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexyJ Neurol2008255121900190318825431
   PubMed Web of Science ®Google Scholar
• KnudsenSMikkelsenJDBangBGammeltoftSJennumPJIntravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexyNeuropediatrics201041521722221210337
   PubMed Web of Science ®Google Scholar
• BarbierAJBerridgeCDugovicCAcute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonistBr J Pharmacol2004143564966115466448
   PubMed Web of Science ®Google Scholar
• GuoRXAnacletCRobertsJCDifferential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleepwake cycle and narcoleptic episodes in Ox-/- miceBr J Pharmacol2009157110411719413575
   PubMed Web of Science ®Google Scholar
• TedfordCEPhillipsJGGregoryRDevelopment of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligandsJ Pharmacol Exp Ther199928921160116810215700
   PubMed Web of Science ®Google Scholar
• BagaiKMalowBAA novel approach to treating morning sleep inertia in narcolepsyJ Clin Sleep Med201061777820191943
   PubMed Web of Science ®Google Scholar